In our previous study, whole–exome sequencing of 127 NKTCL patients revealed that 8.7% harboured somatic mutations in GNAQ, specifically the T96S mutation in the Gαq protein,16 and GNAQ T96S mutations were associated with advanced tumour stage and inferior clinical outcomes in NKTCL. The gene discussed is GNAQ; the disease is neoplasm.